Document Detail


The checkpoint kinase ATM protects against stress-induced elevation of cyclin D1 and potential cell death in neurons.
MedLine Citation:
PMID:  20506465     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Quantitative cytometric studies show that cyclin D1 levels must decline during S phase for proper cell cycle progression, and that cyclin D1 decline follows phosphorylation induced by the checkpoint kinases ataxia telangiectasia mutated (ATM) and ATM and Rad3-related (ATR). ATM is mutated in ataxia telangiectasia (AT), a disease characterized by progressive neurodegeneration. Importantly, neurodegeneration in many cases has been linked to the increased expression of cyclin D1 in neurons leading to inappropriate cell cycle entry. These facts prompted us to test the possibility that ATM normally protects against neural degeneration by suppressing cyclin D1 levels, particularly following genotoxic stress. For this purpose, neural stem cells were induced to differentiate into mature neural cells, including neurons. ATM activity in these cultures was inhibited with a specific chemical inhibitor in the presence or absence of hydrogen peroxide treatment, and the effect on cyclin D1 expression was determined by quantitative, single cell cytometric analyses. As predicted, inhibition of ATM did promote elevation of cyclin D1 in differentiated neurons, particularly under conditions of oxidative stress. The survival of differentiated neurons and of neural stem cells was reduced by such treatments. These data support our suggestion that ATM functions to maintain low levels of cyclin D1 expression in differentiated neurons; and may provide important clues in understanding neural degeneration in general.
Authors:
Masahiro Hitomi; Dennis W Stacey
Related Documents :
15122585 - Overexpression of cdk4/cyclin d1, a possible mediator of apoptosis and an indicator of ...
19763795 - Bcl2l12a localizes to the cell nucleus and induces growth inhibition through g2/m arres...
11078605 - Identification and cloning of a cd43-associated serine/threonine kinase.
12242655 - Effects of erbb-2 overexpression on mitogenic signalling and cell cycle progression in ...
25492185 - A novel poly(propylene-co-imidazole) based biofuel cell: system optimization and operat...
9755245 - Activation of protein kinase calpha couples cell volume to membrane cl- permeability in...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Cytometry. Part A : the journal of the International Society for Analytical Cytology     Volume:  77     ISSN:  1552-4930     ISO Abbreviation:  Cytometry A     Publication Date:  2010 Jun 
Date Detail:
Created Date:  2010-05-27     Completed Date:  2010-09-15     Revised Date:  2011-11-02    
Medline Journal Info:
Nlm Unique ID:  101235694     Medline TA:  Cytometry A     Country:  United States    
Other Details:
Languages:  eng     Pagination:  524-33     Citation Subset:  IM    
Copyright Information:
Copyright 2010 International Society for Advancement of Cytometry.
Affiliation:
Department of Molecular Genetics, The Lerner Research Institute, The Cleveland Clinic, Cleveland, Ohio, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Ataxia Telangiectasia* / metabolism
Cell Cycle Proteins / metabolism*
Cell Death*
Cell Line
Cyclin D1 / genetics,  metabolism*
DNA-Binding Proteins / metabolism*
Down-Regulation
Flow Cytometry
Humans
Neurons / cytology,  metabolism*
Oxidative Stress*
Protein-Serine-Threonine Kinases / metabolism*
Tumor Suppressor Proteins / metabolism*
Chemical
Reg. No./Substance:
0/Cell Cycle Proteins; 0/DNA-Binding Proteins; 0/Tumor Suppressor Proteins; 136601-57-5/Cyclin D1; EC 2.7.11.1/Protein-Serine-Threonine Kinases; EC 2.7.11.1/ataxia telangiectasia mutated protein

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Monitoring working conditions and health of older workers in Dutch construction industry.
Next Document:  Refining the white blood cell differential: The first flow cytometry routine application.